Viewing Study NCT03501368


Ignite Creation Date: 2025-12-24 @ 5:28 PM
Ignite Modification Date: 2025-12-26 @ 8:05 PM
Study NCT ID: NCT03501368
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2018-04-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module